Industrial - Machinery
Compare Stocks
5 / 10Stock Comparison
PNR vs RXO vs XYL vs CHRW vs EXPD
Revenue, margins, valuation, and 5-year total return — side by side.
Trucking
Industrial - Machinery
Integrated Freight & Logistics
Integrated Freight & Logistics
PNR vs RXO vs XYL vs CHRW vs EXPD — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Industrial - Machinery | Trucking | Industrial - Machinery | Integrated Freight & Logistics | Integrated Freight & Logistics |
| Market Cap | $12.41B | $3.58B | $27.04B | $20.33B | $20.84B |
| Revenue (TTM) | $4.20B | $4.31B | $9.09B | $16.20B | $11.19B |
| Net Income (TTM) | $671M | $-69M | $973M | $599M | $837M |
| Gross Margin | 40.9% | 17.5% | 38.6% | 8.3% | 20.2% |
| Operating Margin | 20.6% | -0.2% | 13.6% | 4.9% | 9.7% |
| Forward P/E | 14.4x | 1250.0x | 20.6x | 27.8x | 23.6x |
| Total Debt | $1.64B | $861M | $1.94B | $1.63B | $571M |
| Cash & Equiv. | $102M | $18M | $1.48B | $161M | $1.31B |
PNR vs RXO vs XYL vs CHRW vs EXPD — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Oct 22 | May 26 | Return |
|---|---|---|---|
| Pentair plc (PNR) | 100 | 178.9 | +78.9% |
| RXO, Inc. (RXO) | 100 | 103.6 | +3.6% |
| Xylem Inc. (XYL) | 100 | 111.0 | +11.0% |
| C.H. Robinson World… (CHRW) | 100 | 175.4 | +75.4% |
| Expeditors Internat… (EXPD) | 100 | 160.1 | +60.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: PNR vs RXO vs XYL vs CHRW vs EXPD
Each card shows where this stock fits in a portfolio — not just who wins on paper.
PNR has the current edge in this matchup, primarily because of its strength in value and quality.
- Lower P/E (14.4x vs 23.6x), PEG 1.10 vs 2.99
- 16.0% margin vs RXO's -1.6%
RXO is the clearest fit if your priority is growth exposure.
- Rev growth 26.2%, EPS growth 72.8%, 3Y rev CAGR 6.2%
- 26.2% revenue growth vs CHRW's -8.4%
XYL is the clearest fit if your priority is income & stability and valuation efficiency.
- Dividend streak 15 yrs, beta 0.90, yield 1.4%
- PEG 0.90 vs CHRW's 5.19
- Beta 0.90, yield 1.4%, current ratio 1.63x
CHRW is the #2 pick in this set and the best alternative if dividends and momentum is your priority.
- 1.4% yield, 5-year raise streak, vs EXPD's 1.0%, (1 stock pays no dividend)
- +94.1% vs PNR's -16.8%
EXPD ranks third and is worth considering specifically for long-term compounding and sleep-well-at-night.
- 248.1% 10Y total return vs CHRW's 163.6%
- Lower volatility, beta 0.75, Low D/E 24.2%, current ratio 1.81x
- Beta 0.75 vs RXO's 2.66, lower leverage
- 17.4% ROA vs RXO's -2.1%, ROIC 48.4% vs -0.2%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 26.2% revenue growth vs CHRW's -8.4% | |
| Value | Lower P/E (14.4x vs 23.6x), PEG 1.10 vs 2.99 | |
| Quality / Margins | 16.0% margin vs RXO's -1.6% | |
| Stability / Safety | Beta 0.75 vs RXO's 2.66, lower leverage | |
| Dividends | 1.4% yield, 5-year raise streak, vs EXPD's 1.0%, (1 stock pays no dividend) | |
| Momentum (1Y) | +94.1% vs PNR's -16.8% | |
| Efficiency (ROA) | 17.4% ROA vs RXO's -2.1%, ROIC 48.4% vs -0.2% |
PNR vs RXO vs XYL vs CHRW vs EXPD — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
PNR vs RXO vs XYL vs CHRW vs EXPD — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
PNR leads in 2 of 6 categories
EXPD leads 2 • CHRW leads 1 • RXO leads 0 • XYL leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
PNR leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CHRW is the larger business by revenue, generating $16.2B annually — 3.9x PNR's $4.2B. PNR is the more profitable business, keeping 16.0% of every revenue dollar as net income compared to RXO's -1.6%. On growth, EXPD holds the edge at +4.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $4.2B | $4.3B | $9.1B | $16.2B | $11.2B |
| EBITDAEarnings before interest/tax | $983M | $77M | $1.8B | $896M | $1.1B |
| Net IncomeAfter-tax profit | $671M | -$69M | $973M | $599M | $837M |
| Free Cash FlowCash after capex | $716M | -$15M | $966M | $858M | $921M |
| Gross MarginGross profit ÷ Revenue | +40.9% | +17.5% | +38.6% | +8.3% | +20.2% |
| Operating MarginEBIT ÷ Revenue | +20.6% | -0.2% | +13.6% | +4.9% | +9.7% |
| Net MarginNet income ÷ Revenue | +16.0% | -1.6% | +10.7% | +3.7% | +7.5% |
| FCF MarginFCF ÷ Revenue | +17.0% | -0.3% | +10.6% | +5.3% | +8.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | +2.6% | -99.9% | +2.7% | -0.8% | +4.4% |
| EPS Growth (YoY)Latest quarter vs prior year | +12.9% | -16.7% | +14.5% | +9.9% | +16.3% |
Valuation Metrics
PNR leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 19.4x trailing earnings, PNR trades at a 45% valuation discount to CHRW's 35.5x P/E. Adjusting for growth (PEG ratio), XYL offers better value at 1.27x vs CHRW's 6.62x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $12.4B | $3.6B | $27.0B | $20.3B | $20.8B |
| Enterprise ValueMkt cap + debt − cash | $14.0B | $4.4B | $27.5B | $21.8B | $20.1B |
| Trailing P/EPrice ÷ TTM EPS | 19.40x | -36.86x | 29.02x | 35.48x | 26.33x |
| Forward P/EPrice ÷ next-FY EPS est. | 14.35x | 1250.00x | 20.56x | 27.83x | 23.61x |
| PEG RatioP/E ÷ EPS growth rate | 1.48x | — | 1.27x | 6.62x | 3.34x |
| EV / EBITDAEnterprise value multiple | 14.31x | 40.60x | 15.29x | 24.28x | 18.11x |
| Price / SalesMarket cap ÷ Revenue | 2.97x | 0.62x | 2.99x | 1.25x | 1.88x |
| Price / BookPrice ÷ Book value/share | 3.29x | 2.38x | 2.36x | 11.28x | 9.05x |
| Price / FCFMarket cap ÷ FCF | 16.64x | — | 29.71x | 22.72x | 21.86x |
Profitability & Efficiency
EXPD leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
EXPD delivers a 36.7% return on equity — every $100 of shareholder capital generates $37 in annual profit, vs $-4 for RXO. XYL carries lower financial leverage with a 0.17x debt-to-equity ratio, signaling a more conservative balance sheet compared to CHRW's 0.88x. On the Piotroski fundamental quality scale (0–9), PNR scores 8/9 vs XYL's 6/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +17.7% | -4.4% | +8.5% | +33.3% | +36.7% |
| ROA (TTM)Return on assets | +9.9% | -2.1% | +5.6% | +11.5% | +17.4% |
| ROICReturn on invested capital | +12.1% | -0.2% | +7.6% | +18.0% | +48.4% |
| ROCEReturn on capital employed | +15.0% | -0.3% | +8.5% | +25.6% | +38.2% |
| Piotroski ScoreFundamental quality 0–9 | 8 | 6 | 6 | 7 | 8 |
| Debt / EquityFinancial leverage | 0.42x | 0.56x | 0.17x | 0.88x | 0.24x |
| Net DebtTotal debt minus cash | $1.5B | $843M | $463M | $1.5B | -$744M |
| Cash & Equiv.Liquid assets | $102M | $18M | $1.5B | $161M | $1.3B |
| Total DebtShort + long-term debt | $1.6B | $861M | $1.9B | $1.6B | $571M |
| Interest CoverageEBIT ÷ Interest expense | 11.94x | -3.15x | 49.32x | 6.27x | — |
Total Returns (Dividends Reinvested)
CHRW leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CHRW five years ago would be worth $18,012 today (with dividends reinvested), compared to $10,064 for XYL. Over the past 12 months, CHRW leads with a +94.1% total return vs PNR's -16.8%. The 3-year compound annual growth rate (CAGR) favors CHRW at 20.2% vs XYL's 3.3% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -26.7% | +69.4% | -16.7% | +5.1% | +3.2% |
| 1-Year ReturnPast 12 months | -16.8% | +50.7% | -6.4% | +94.1% | +43.5% |
| 3-Year ReturnCumulative with dividends | +36.1% | +12.4% | +10.1% | +73.7% | +38.2% |
| 5-Year ReturnCumulative with dividends | +17.9% | +3.6% | +0.6% | +80.1% | +36.3% |
| 10-Year ReturnCumulative with dividends | +121.3% | +3.6% | +200.2% | +163.6% | +248.1% |
| CAGR (3Y)Annualised 3-year return | +10.8% | +4.0% | +3.3% | +20.2% | +11.4% |
Risk & Volatility
EXPD leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
EXPD is the less volatile stock with a 0.75 beta — it tends to amplify market swings less than RXO's 2.66 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. EXPD currently trades 93.7% from its 52-week high vs PNR's 67.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.21x | 2.66x | 0.90x | 0.97x | 0.75x |
| 52-Week HighHighest price in past year | $113.95 | $23.37 | $154.27 | $203.34 | $167.19 |
| 52-Week LowLowest price in past year | $76.69 | $10.43 | $113.46 | $87.41 | $108.36 |
| % of 52W HighCurrent price vs 52-week peak | +67.4% | +93.1% | +73.7% | +84.3% | +93.7% |
| RSI (14)Momentum oscillator 0–100 | 33.7 | 74.6 | 40.4 | 45.9 | 56.9 |
| Avg Volume (50D)Average daily shares traded | 1.6M | 1.9M | 2.1M | 1.7M | 1.1M |
Analyst Outlook
Evenly matched — CHRW and EXPD each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: PNR as "Hold", RXO as "Hold", XYL as "Hold", CHRW as "Hold", EXPD as "Hold". Consensus price targets imply 47.8% upside for PNR (target: $114) vs -10.3% for RXO (target: $20). For income investors, CHRW offers the higher dividend yield at 1.45% vs EXPD's 0.97%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold | Hold | Hold | Hold |
| Price TargetConsensus 12-month target | $113.56 | $19.50 | $151.57 | $187.38 | $143.44 |
| # AnalystsCovering analysts | 41 | 20 | 40 | 46 | 33 |
| Dividend YieldAnnual dividend ÷ price | +1.3% | — | +1.4% | +1.4% | +1.0% |
| Dividend StreakConsecutive years of raises | 6 | — | 15 | 5 | 31 |
| Dividend / ShareAnnual DPS | $0.99 | — | $1.60 | $2.48 | $1.52 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.8% | +0.0% | +0.1% | +1.7% | +3.2% |
PNR leads in 2 of 6 categories (Income & Cash Flow, Valuation Metrics). EXPD leads in 2 (Profitability & Efficiency, Risk & Volatility). 1 tied.
PNR vs RXO vs XYL vs CHRW vs EXPD: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is PNR or RXO or XYL or CHRW or EXPD a better buy right now?
For growth investors, RXO, Inc.
(RXO) is the stronger pick with 26. 2% revenue growth year-over-year, versus -8. 4% for C. H. Robinson Worldwide, Inc. (CHRW). Pentair plc (PNR) offers the better valuation at 19. 4x trailing P/E (14. 4x forward), making it the more compelling value choice. Analysts rate Pentair plc (PNR) a "Hold" — based on 41 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — PNR or RXO or XYL or CHRW or EXPD?
On trailing P/E, Pentair plc (PNR) is the cheapest at 19.
4x versus C. H. Robinson Worldwide, Inc. at 35. 5x. On forward P/E, Pentair plc is actually cheaper at 14. 4x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Xylem Inc. wins at 0. 90x versus C. H. Robinson Worldwide, Inc. 's 5. 19x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — PNR or RXO or XYL or CHRW or EXPD?
Over the past 5 years, C.
H. Robinson Worldwide, Inc. (CHRW) delivered a total return of +80. 1%, compared to +0. 6% for Xylem Inc. (XYL). Over 10 years, the gap is even starker: EXPD returned +248. 1% versus RXO's +3. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — PNR or RXO or XYL or CHRW or EXPD?
By beta (market sensitivity over 5 years), Expeditors International of Washington, Inc.
(EXPD) is the lower-risk stock at 0. 75β versus RXO, Inc. 's 2. 66β — meaning RXO is approximately 256% more volatile than EXPD relative to the S&P 500. On balance sheet safety, Xylem Inc. (XYL) carries a lower debt/equity ratio of 17% versus 88% for C. H. Robinson Worldwide, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — PNR or RXO or XYL or CHRW or EXPD?
By revenue growth (latest reported year), RXO, Inc.
(RXO) is pulling ahead at 26. 2% versus -8. 4% for C. H. Robinson Worldwide, Inc. (CHRW). On earnings-per-share growth, the picture is similar: RXO, Inc. grew EPS 72. 8% year-over-year, compared to 4. 0% for Expeditors International of Washington, Inc.. Over a 3-year CAGR, XYL leads at 17. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — PNR or RXO or XYL or CHRW or EXPD?
Pentair plc (PNR) is the more profitable company, earning 15.
7% net margin versus -1. 7% for RXO, Inc. — meaning it keeps 15. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PNR leads at 20. 5% versus -0. 1% for RXO. At the gross margin level — before operating expenses — PNR leads at 40. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is PNR or RXO or XYL or CHRW or EXPD more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Xylem Inc. (XYL) is the more undervalued stock at a PEG of 0. 90x versus C. H. Robinson Worldwide, Inc. 's 5. 19x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Pentair plc (PNR) trades at 14. 4x forward P/E versus 1250. 0x for RXO, Inc. — 1235. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PNR: 47. 8% to $113. 56.
08Which pays a better dividend — PNR or RXO or XYL or CHRW or EXPD?
In this comparison, CHRW (1.
4% yield), XYL (1. 4% yield), PNR (1. 3% yield), EXPD (1. 0% yield) pay a dividend. RXO does not pay a meaningful dividend and should not be held primarily for income.
09Is PNR or RXO or XYL or CHRW or EXPD better for a retirement portfolio?
For long-horizon retirement investors, Expeditors International of Washington, Inc.
(EXPD) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 75), 1. 0% yield, +248. 1% 10Y return). RXO, Inc. (RXO) carries a higher beta of 2. 66 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (EXPD: +248. 1%, RXO: +3. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between PNR and RXO and XYL and CHRW and EXPD?
Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: PNR is a mid-cap quality compounder stock; RXO is a small-cap high-growth stock; XYL is a mid-cap quality compounder stock; CHRW is a mid-cap quality compounder stock; EXPD is a mid-cap quality compounder stock. PNR, XYL, CHRW, EXPD pay a dividend while RXO does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.